The science is clear: recent scientific advances in our understanding of the impact of HIV treatment have shown that achieving and maintaining viral suppression improves the health of those living with HIV and prevents the transmission of new infections. Further, data modeling shows that achieving viral suppression among people living with HIV is the single most effective strategy for reducing new infections and ending the epidemic in the United States.
The National HIV/AIDS Strategy (NHAS) sets our target for increasing the percentage of persons diagnosed with HIV who are virally suppressed to at least 80% by 2020. The NHAS target for viral suppression is consistent with the UNAIDS 90-90-90 targets for 2020 which strive for 90% of people living with HIV around the world knowing their status, 90% of people living with HIV who know their status receiving antiretroviral therapy (ART), and 90% of people living with HIV who know their status and receiving ART being virally suppressed. If you do the math, this is equal to about 73% of all people living with HIV being virally suppressed. Achieving the NHAS targets would result in a similar result in the U.S.: increasing the percentage of people in the U.S. with diagnosed HIV infection to 90% and increasing the percentage of those individuals who are virally suppressed to 80 percent results in 72% of people diagnosed with HIV in the U.S. being virally suppressed. UNAIDS modeling suggests that achieving the 90-90-90 targets by 2020 will enable the world to end the AIDS epidemic by 2030, which in turn will generate profound health and economic benefits.
The Monitoring Report [PDF, 2.31 MB ] released in July 2017 by the Centers for Disease Control and Prevention (CDC) shows that our NHAS annual target (54.5%) for the percentage of people living with diagnosed HIV infection who were virally suppressed in 2014 was exceeded (57.9%). This is consistent with results in prior years in which we exceeded our annual targets for viral suppression each year, putting us on track to meet our 2020 NHAS target.
The NHAS indicator and the HHS Core HIV Indicators define viral suppression as having a viral load result of <200 copies/mL at the most recent viral load test. CDC monitors viral suppression using laboratory data from jurisdictions with complete reporting of CD4 and viral load tests. In 2014, there were 38 jurisdictions with complete laboratory reporting, representing 72% of all people ≥13 years old living with diagnosed HIV in the U.S.
Despite exceeding the latest NHAS annual target overall, when we look at the data further, we see a number of groups who are being left behind in America. In 2014, we failed to meet the annual target for viral suppression (54.5%) among:
People below the age of 34, including ages 13-24 (48.1%) and ages 24-34 (52.3%); Black/African Americans (51.5%);People who inject drugs, including men (48.4%) and women (53.2%); andHeterosexual men (53.5%).
It is critical that we address these disparities to ensure that we can continue to meet our annual targets moving forward and ultimately reach or even exceed the NHAS 2020 target.
Achieving the 2020 target will also require that we continue to make improvements along each step of the HIV care continuum. This may be made easier by the recent scientific advances that provide the basis for the shift toward immediate treatment upon diagnosis and may, in time, reduce HIV stigma and its impact on individuals accessing HIV testing, care, and treatment.
In addition, increasing viral suppression will also require that we continue to make important progress in expanding efforts to reengage individuals in HIV care through strategies such as Data to Care, in improving delivery of care in health centers and other settings, and in building sustainable partnerships among health departments and health centers such as in the Partnerships for Care program administered by the CDC and Health Resources and Services Administration with the support of funding from the Secretary’s Minority AIDS Initiative Fund. It will also require that we ensure we have the capacity and resources to care for more and more of those who we newly engage in care while continuing to care for all those who are already in HIV care. Further, it will require that we address, head-on, other factors that impede someone from achieving viral suppression such as stigma, limited access to holistic health care, which treats the entire person, and other barriers to economic and social well-being.